A better future for everyone. This ambition motivates our scientists in executing their leading research and inspiring teaching. At
Utrecht University, the various disciplines collaborate intensively towards major
strategic themes. Our focus is on Dynamics of Youth, Institutions for Open Societies, Life Sciences and Pathways to Sustainability.
Sharing science, shaping tomorrow.
At the
Faculty of Science there are six departments to make a fundamental connection with: Biology, Chemistry, Information and Computing Sciences, Mathematics, Pharmaceutical Sciences and Physics. Each of these is made up of distinct institutes that work together to focus on answering some of humanity’s most pressing challenges. More fundamental still are the individual research groups – the building blocks of our ambitious scientific projects. Find out more about us on
YouTube.
You will be employed within the
Division of Pharmacoepidemiology and Clinical Pharmacology, one of the five divisions of the
Utrecht Institute for Pharmaceutical Sciences (UIPS). This is the research institute of the Department of Pharmaceutical Sciences of Utrecht University.
The Division of Pharmacoepidemiology and Clinical Pharmacology comprises a multidisciplinary team of young, internationally oriented-researchers. The research programme is directed at several epidemiological, therapeutic, and policy aspects of chronic drug use, focusing on advanced, affordable biomolecular and cellular therapies. The PhD position falls under the Centre for Pharmaceutical Policy & Regulation (one of the three Centres of the Division). The Centre aims to develop, assess, and apply innovative methods in pharmaceutical policy, drug regulatory science, and health technology assessment (HTA). For this, an integrated approach to the drug life cycle and the context in which medicines are developed, assessed, and used is taken. Necessary research spearheaded by the Centre includes questions on authorisation, access to, and affordability of medicines. One of the unique features of the Centre is that it works closely with experts from the Dutch Medicines Evaluation Board (MEB), the Dutch National Health Care Institute (ZIN), and the International Pharmaceutical Federation (FIP). The WHO Collaborating Centre for Pharmaceutical Policy and Regulation is embedded in the Centre, which focuses on global access to medicines in pharmaceutical systems—the centre partners with the Regulatory Science Network Netherlands (RSNN) and the Academic Research Network HTA.